Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
The Journal of Investigative Dermatology|February 12, 2017
AURKA Overexpression Is Driven by FOXM1 and MAPK/ERK Activation in Melanoma Cells Harboring BRAF or NRAS Mutations: Impact on Melanoma Prognosis and TherapyJoan Anton Puig-Butille, Antònia Vinyals, Josep R Ferreres, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2014
Phase II randomized study of figitumumab plus docetaxel and docetaxel alone with crossover for metastatic castration-resistant prostate cancerJohann S de Bono, Josep M Piulats, Hardev S Pandha, et al.
Frontiers in Medicine|January 26, 2023
1,4-dihydroxy quininib modulates the secretome of uveal melanoma tumour explants and a marker of oxidative phosphorylation in a metastatic xenograft modelKayleigh Slater, Rosa Bosch, Kaelin Francis Smith, et al.
Cancer Medicine|May 22, 2023
Differences in glucose metabolic activity in liver metastasis separates two groups of metastatic uveal melanoma patients with different prognosisLuis P Del Carpio, María Asunción Algarra, Aida Sabaté-Llobera, et al.
Dermatology and Therapy|September 24, 2021
Health-Related Quality of Life of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma Treated with Pembrolizumab in KEYNOTE-629Brett G M Hughes, Rene Gonzalez Mendoza, Nicole Basset-Seguin, et al.
Cell Death Discovery|February 10, 2024
1,4-dihydroxy quininib activates ferroptosis pathways in metastatic uveal melanoma and reveals a novel prognostic biomarker signatureValentina Tonelotto, Marcel Costa-Garcia, Eve O'Reilly, et al.
The Journal of Investigative Dermatology|December 27, 2019
T-Type Calcium Channels as Potential Therapeutic Targets in Vemurafenib-Resistant BRAF<sup>V600E</sup> MelanomaCarla Barceló, Pol Sisó, Oscar Maiques, et al.
Nature Communications|March 11, 2025
Tebentafusp, a T cell engager, promotes macrophage reprogramming and in combination with IL-2 overcomes macrophage immunosuppression in cancerEsra Güç, Agatha Treveil, Emma Leach, et al.
Nature Communications|June 24, 2024
Cancer cell plasticity defines response to immunotherapy in cutaneous squamous cell carcinomaLaura Lorenzo-Sanz, Marta Lopez-Cerda, Victoria da Silva-Diz, et al.
Cancers|October 17, 2020
High Cysteinyl Leukotriene Receptor 1 Expression Correlates with Poor Survival of Uveal Melanoma Patients and Cognate Antagonist Drugs Modulate the Growth, Cancer Secretome, and Metabolism of Uveal Melanoma CellsKayleigh Slater, Aisling B Heeran, Sandra Garcia-Mulero, et al.
Pageof 7